INTERLEUKIN FOUNDATION (EIN 271170242) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

CHARLES DINARELLO

Phone

3034730818

Tax Period

2023-01-01 to 2023-12-31

INTERLEUKIN FOUNDATION, founded in 2009, is a small nonprofit in the Medical Research sector that reported $219K in total revenue in fiscal year 2023. Expenses of $277K exceeded revenue, resulting in a 26% operating deficit.

Mission

PROVIDE FUNDS FOR BASIC AND APPLIED MEDICAL RESEARCH. RAISE AND DISTRIBUTE MONEY FOR EXPERT SCIENTIFIC INVESTIGATORS IN ACADEMIC CENTERS AROUND THE WORLD. ADVANCE THE TREATMENT OF INFLAMMATION AND DYSFUNCTIONAL IMMUNE RESPONSES BY SUPPORTING RESEARCH IN THE FIELD OF INTERLEUKINS, SMALL PROTEINS PRODUCED NATURALLY DURING INFECTIONS AND INJURY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $218,841

Program Service Revenue $0

Investment Income $38

Other Revenue $0

TOTAL REVENUE $218,879

Expense Breakdown

Grants Paid $273,700

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $273,700

Other Expenses $3,092

TOTAL EXPENSES $276,792

Year-over-Year Comparison

	2023	2022	Change
Revenue	$218,879	$219,319	0.0%
Expenses	$276,792	$274,900	+0.0%
Net Income	$-57,913	$-55,581	+0.0%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHARLES DINARELLO MD	PRESIDENT	5.00	Director	$0	$0	$0
DANIELA NOVICK PHD	VICE PRESIDENT	1.50	Director	$0	$0	$0
MIHAI NETEA MD	DIRECTOR	1.50	Director	$0	$0	$0
THOMAS MANDRUP-POULSEN MDPHD	DIRECTOR	1.00	Director	$0	$0	$0
ANNA RUBARTELLI MDPHD	DIRECTOR	1.00	Director	$0	$0	$0
JAMES MIER MD	DIRECTOR	1.00	Director	$0	$0	$0
FABIO COMINELLI MDPHD	DIRECTOR	1.00	Director	$0	$0	$0
JESUS RIVERA-NIEVES MD	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$218,879	$276,792	$362,008	$-57,913
2022	$219,319	$274,900	$419,921	$-55,581
2021	$655,252	$496,135	$475,501	$159,117
2020	$544,259	$388,324	$316,384	$155,935
2019	$194,937	$226,306	$160,449	$-31,369
2018	$187,988	$214,232	$191,818	$-26,244

INTERLEUKIN FOUNDATION